Director Douglas J. Treff filed a Form 4 with the SEC on November 4, 2026, disclosing the sale of 14,802 shares of Crocs, Inc. common stock across four transactions on November 2, 2026.
Kyle Clark, an officer of BETA Technologies, Inc., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 10,000 shares of common stock on the NYSE under the ticker NYSE:BETA.
FTI Consulting, Inc. officer Paul Linton filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 2,000 shares of common stock following a stock option exercise on the same date.
Capital One Financial Corporation Chairman and CEO Richard D. Fairbank filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 90,743 shares of Capital One common stock with an aggregate market value of $18,589,335.46.
Director Bruce C. Cozadd filed a Form 4 with the SEC on November 4, 2026, disclosing a sale of 6,000 ordinary shares of Jazz Pharmaceuticals plc on November 2, 2026, executed under a pre-established Rule 10b5-1 trading plan.
Jazz Pharmaceuticals Public Limited Company officer Patricia Carr filed a Form 144 notice of proposed sale of 1,413 shares of common stock, with an approximate sale date of November 4, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services.
Gartner, Inc. officer Thomas S. Kim filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 3,693 shares of Gartner common stock with an aggregate market value of $758,948.43.
Clarivate PLC officer Jonathan M. Collins filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 84,663 common shares on the NYSE with an aggregate market value of $190,491.75.
Director Richard D. Fain filed a Form 4 with the SEC on November 4, 2026, disclosing a disposition of 5,605 shares of Royal Caribbean Cruises Ltd. common stock on November 2, 2026, through a gift transaction.
AWILHELMSEN AS, a director-affiliated entity of Royal Caribbean Cruises Ltd., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 500,000 shares of Royal Caribbean common stock through Oppenheimer & Co Inc.